Ivan Lozic

Dr Ivan Lozic is the Small Animal Imaging Specialist at the Centre for Microscopy, Characterisation and Analysis (CMCA) at the University of Western Australia (UWA). He provides training to new users at the CMCA, advising in experimental design, data acquisition and analysis. Ivan has worked in a range of scientific support roles, involving the use of a range of different analytical techniques: optical/confocal microscopy, fluorescence imaging, nano-scale mass spectrometry, NMR, ultrasound and CT.

In addition, he has experience in the design and development of targeted therapeutic delivery nanoparticles and their multi-modal imaging in animal models. His interests involve the multidisciplinary application of complementary analytical and imaging techniques in biomedical research.

Uwe Ackermann

I graduated with a PhD in chemistry from the University of Heidelberg, Germany in 1995. I spent a year as a Postdoc at Cornell University in Ithaca, NY, then worked as a medicinal chemist for GlaxoSmithKline in Cape Town, South Africa.
I joined Austin Health in 1998 as a radiochemist. Initially, I did a lot of carbon-11 work and established the procedure for the first C-11 PIB scan in Australia. I have extensive experience in performing first-in-human studies with neuroscience and oncology tracers labelled with C-11, F-18 and Zr-89. My main research interests are in synthesis automation, labelling of peptides ad antibodies as well as hypoxia.

John Doan

John has over 12 years’ experience in the field of radiopharmaceutical sciences (including basic sciences to clinical application). At his most recent long term position (2016-2019) he was employed as a Quality Assurance Officer / PET Development Radiochemist at the Clinical PET Centre, King’s College London (KCL). John has an interest and passion to deliver high-quality radiopharmaceuticals in a public health and research environment including the development of novel and established radiopharmaceuticals for preclinical use and clinical use.

Katie McMahon

Professor Katie McMahon is the Director of the Herston Imaging Research Facility (HIRF).

Prof McMahon’s research interests lie in understanding the neurobiology of language, learning and memory, and the genetic and environmental influences on brain structure and function.

When these systems fail, either due to stroke or a degenerative disease like Parkinson’s, imaging markers of lesion size, position and brain network damage might be able to be used to optimise therapeutic intervention, by providing insights on the best type of therapy. She is also investigating behavioural and neurological markers in children with language development problems, such as autism or specific language impairment.

In addition, Prof McMahon collaborates on work looking at musculoskeletal function and MRI markers in whiplash.


Privacy Settings
Google Maps